The Visian ICL, or commonly referred to as the “implantable contact lens”, is the next generation of vision correction that’s still the hidden gem of the eyecare world. With over 1,000,000 lenses implanted worldwide, this best-kept secret is ready to make its debut next to other traditional eye procedures.
A 3 year study was conducted after the Visian ICL lenses were implanted in 92 patients and yielded overall stable results throughout the follow-up period. This indicated that the lens were predictable, stable, safe, and effective to correct myopia in the long term. Those who qualified for the Visian ICL procedure were between the ages of 21 and 45 years old and had myopia from -3D to -20D.
What Are Toric Lenses - The Toric Visian ICL
The Toric Visian ICL was recently approved by the FDA last year, giving more options to patients who seek a vision correction option.
The Toric Visian ICL can treat those who:
- Are between the ages of 21 and 45 years
- Have astigmatism up to -4D
- Have myopia, or nearsightedness, between -3D to -15D
A study done from 2009 - 2013 at the University of Toronto Medical School examined 44 patients who received the Visian ICL and Toric Visian ICL. 36 of the 44 patients opted to receive the toric lenses to treat both their astigmatism and myopia. Over the 14 month study, over half the patients reported that they achieved 20/20 vision for both the Visian ICL lens and Toric Visian ICL lens.